Top Banner
Osimertinib Mesylate Intermediates | EOS MED CHEM www.eosmedchem.com
7

Osimertinib Mesylate Intermediates | EOS MED CHEM

Apr 15, 2017

Download

Health & Medicine

EOS Med Chem
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Osimertinib Mesylate Intermediates | EOS MED CHEM

Osimertinib Mesylate Intermediates | EOS MED CHEM

www.eosmedchem.com

Page 2: Osimertinib Mesylate Intermediates | EOS MED CHEM

Osimertinib (azd9291) is also known as Tagrisso™. It is prescribed for that patient who has non-small cell lung cancer disease. It is a positive mutant-selective EGFR inhibitor and it works as drug resistance in cancer cells. For more info visit:

http://www.eosmedchem.com/1421373-65-0.html

About Osimertinib azd9291

Page 3: Osimertinib Mesylate Intermediates | EOS MED CHEM

Non- small Lung cancer starts when cells of the lung become anomalous and begin to develop the threatening condition. As

more cancer cells develop, they can turn into a tumor and spread to other parts of the body.

Info of Non- Small Lung Cancer

Page 4: Osimertinib Mesylate Intermediates | EOS MED CHEM

Types of Non- Small Lung Cancer

1. Lung Adenocarcinoma2. Squamous Cell Carcinoma3. Large Cell Carcinoma

Page 5: Osimertinib Mesylate Intermediates | EOS MED CHEM

Symptoms of Non- Small Lung Cancer

1. Shortness of breath2. Back and shoulder pain3. Fatigue4. Metastasis5. Pleuritic chest pain

Page 6: Osimertinib Mesylate Intermediates | EOS MED CHEM

Osimertinib azd9291 for Non-Small Cell Lung Cancer

Page 7: Osimertinib Mesylate Intermediates | EOS MED CHEM

Contact Us

EOS Med Chem, Medicinal Chemical is Big www.eosmedchem.com

Tel : 86-531-69905422Fax : [email protected]

[email protected]